These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23619482)

  • 1. Tacrolimus-induced cerebral blindness in a liver transplant patient.
    Tamhankar MA; Lesniak SP; Nallasamy S; Woo JH
    Indian J Ophthalmol; 2016 Jul; 64(7):541. PubMed ID: 23619482
    [No Abstract]   [Full Text] [Related]  

  • 2. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.
    Steg RE; Kessinger A; Wszolek ZK
    Bone Marrow Transplant; 1999 May; 23(9):959-62. PubMed ID: 10338054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome.
    Catalano G; De Simone P; Mazzoni A; Ghinolfi D; Coletti L; Filipponi F
    Transpl Int; 2014 Sep; 27(9):e84-6. PubMed ID: 24606320
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus: immunosuppression following liver and kidney transplant.
    Clark W
    J Clin Pharm Ther; 1996 Jun; 21(3):135-41. PubMed ID: 8873845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressant neurotoxicity in liver transplant recipients. Clinical challenges for the consultation-liaison psychiatrist.
    Strouse TB; el-Saden SM; Glaser NE; Bonds C; Ayars N; Busuttil RW
    Psychosomatics; 1998; 39(2):124-33. PubMed ID: 9584538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Helio Tedesco Silva Jr.
    Silva HT
    Drugs; 2007; 67(13):1944-5. PubMed ID: 17722963
    [No Abstract]   [Full Text] [Related]  

  • 7. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus-induced permanent asymptomatic pontine myelinolysis after liver transplantation.
    Bao J; Liang H
    Intern Med; 2014; 53(15):1713-4. PubMed ID: 25088893
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of tacrolimus in the evolution of liver transplantation.
    Busuttil RW; Lake JR
    Transplantation; 2004 May; 77(9 Suppl):S44-51. PubMed ID: 15201686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M; Corno V; Colledan M; Segalin A; Lucianetti A; Torre G; Riva S; Sonzogni A; Petz W; Gridelli B
    Transpl Int; 2000; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation.
    Scholler G; Rose M; Neuhaus R; Neuhaus P; Klapp BF
    Transplant Proc; 1997 Aug; 29(5):2491-3. PubMed ID: 9270822
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus in transplant rejection.
    Rath T
    Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 20. FK 506 dose in transplantation: from theory to practice.
    Faivre L; Saoudi S; Astier A; Hamadas C; Conort O; Boivin H; Sabatier B; Taburet A; Lecointre K; Bellanger A; Radideau E; Thuillier A
    Transplant Proc; 2001 Jun; 33(4):2594-7. PubMed ID: 11406256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.